作者: SHIGERU KOBAYASHI , MASARU KIHARA , TETSURO SHINGU , KEIJI SHINGU
DOI: 10.1248/CPB.28.2924
关键词:
摘要: Pretazettine (1), which shows antileukemic activity, was obtained by conversion of tazettine (2) to 3-epitazettadiol (3) [whose structure confirmed its cyclization deoxypretazettine (4)], followed manganese dioxide oxidation 3. The transformation 2 1 the stereochemistry pretazettine (1).